Table of Contents
Thrombosis
Volume 2011, Article ID 652796, 8 pages
http://dx.doi.org/10.1155/2011/652796
Research Article

The Use of a Scoring System to Guide Thromboprophylaxis in a High-Risk Pregnant Population

1Department of Women's Services and Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK
2Department of Haematology and Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK

Received 18 February 2011; Accepted 30 June 2011

Academic Editor: I. A. Greer

Copyright © 2011 D. Schoenbeck et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Pulmonary embolism,” in Reports on Public Health and Medical Subjects Number 103. Report on Confidential Enquiries into Maternal Deaths in England and Wales 1955–1957, A. L. Walker, A. J. Wrigley, G. S. Organe, R. N. Chamberlain, and W. J. Martin, Eds., pp. 18–21, HMSO, London, UK, 1960.
  2. J. Drife, “Thrombosis and thromboembolism,” in Saving Mothers’ Lives 2003–2005. Confidential Enquiry into Maternal and Child Health, G. Lewis, Ed., pp. 61–78, RCOG Press, London, UK, 2007. View at Google Scholar
  3. P. Clark, J. Brennand, J. A. Conkie, F. McCall, I. A. Greer, and I. D. Walker, “Activated protein C sensitivity, protein C, protein S, coagulation in normal pregnancy,” Thrombosis and Haemostasis, vol. 79, no. 6, pp. 1166–1170, 1998. View at Google Scholar · View at Scopus
  4. U. Kjellberg, N. E. Andersson, S. Rosen, L. Tengborn, and M. Hellgren, “APC resistance and other haemostatic variables during pregnancy and the puerperium,” Thrombosis and Haemostasis, vol. 81, no. 4, pp. 527–531, 1999. View at Google Scholar
  5. M. D. McColl, J. E. Ramsay, R. C. Tait et al., “Risk factors for pregnancy associated venous thromboembolism,” Thrombosis and Haemostasis, vol. 78, no. 4, pp. 1183–1188, 1997. View at Google Scholar · View at Scopus
  6. F. R. Rosendaal, “Venous thrombosis: a multicausal disease,” The Lancet, vol. 353, no. 9159, pp. 1167–1173, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Weiss and P. S. Bernstein, “Risk factor scoring for predicting venous thromboembolism in obstetric patients,” The American Journal of Obstetrics & Gynecology, vol. 182, no. 5, pp. 1073–1075, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. M. D. McColl, I. D. Walker, and I. A. Greer, “The role of inherited thrombophilia in venous thromboembolism associated with pregnancy,” The British Journal of Obstetrics and Gynaecology, vol. 106, no. 8, pp. 756–766, 1999. View at Google Scholar · View at Scopus
  9. A. Lindhagen, A. Bergqvist, D. Bergqvist, and T. Hallbook, “Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy,” The British Journal of Obstetrics and Gynaecology, vol. 93, no. 4, pp. 348–352, 1986. View at Google Scholar · View at Scopus
  10. A. Bergqvist, D. Bergqvist, A. Lindhagen, and T. Matzsch, “Late symptoms after pregnancy related deep venous thrombosis,” The British Journal of Obstetrics and Gynaecology, vol. 97, pp. 338–341, 1990. View at Google Scholar
  11. C. Nelson-Piercy, E. A. Letsky, and M. de Swiet, “Low molecular weight heparin for obstetric thromboprophylaxis: experience of 69 pregnancies in 61 high risk women,” The American Journal of Obstetrics & Gynecology, vol. 176, pp. 1062–1068, 1996. View at Google Scholar
  12. J. Ellison, I. D. Walker, and I. A. Greer, “Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy,” The British Journal of Obstetrics and Gynaecology, vol. 107, no. 9, pp. 1116–1121, 2000. View at Google Scholar · View at Scopus
  13. T. Matzsch, D. Bergqvist, A. Bergqvist et al., “No transplacental passage of standard heparin or an enzymatically depolymerised low molecular weight heparin,” Blood Coagulation & Fibrinolysis, vol. 2, no. 2, pp. 273–278, 1991. View at Google Scholar · View at Scopus
  14. C. Richter, J. Sitzmann, P. Lang, H. Weitzel, A. Huch, and R. Huch, “Excretion of low molecular weight heparin in human milk,” The British Journal of Clinical Pharmacology, vol. 52, no. 6, pp. 708–710, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Harenberg, U. Hoffmann, G. Huhle, M. Winkler, and C. Bayerl, “Cutaneous reactions to anticoagulants recognition and management,” The American Journal of Clinical Dermatology, vol. 2, no. 2, pp. 69–75, 2001. View at Google Scholar · View at Scopus
  16. J. Shefras and R. G. Farquharson, “Bone density studies in pregnant women receiving heparin,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 65, no. 2, pp. 171–174, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. T. E. Warkentin, M. N. Levine, J. Hirsh et al., “Heparin induced thrombocytopoenia in patients treated with low molecular weight heparin or unfractionated heparin,” The New England Journal of Medicine, vol. 332, no. 20, pp. 1330–1335, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. D. Bergqvist, B. Lindblad, and T. Matzsch, “Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia. Is there a risk?” Acta Anaesthesiologica Scandinavica, vol. 36, no. 7, pp. 605–609, 1992. View at Google Scholar · View at Scopus
  19. Scottish Intercollegiate Guidelines Network, Pregnancy and the Puerperium: Antithrombotic Therapy, SIGN Publication Number 36, SIGN, Edinburgh, Scotland, 1999.
  20. Royal College of Obstetricians and Gynaecologists, Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium, Green-top Guideline Number 37, RCOG Press, London, UK, 2009.
  21. M. D. McColl, I. D. Walker, and I. A. Greer, “The role of inherited thrombophilia in venous thromboembolism associated with pregnancy,” The British Journal of Obstetrics and Gynaecology, vol. 106, no. 8, pp. 756–766, 1999. View at Google Scholar · View at Scopus
  22. I. D. Waker, M. Greaves, and F. E. Preston, “Guideline: investigation and management of heritable thrombophilia,” The British Journal of Haematology, vol. 114, pp. 512–528, 2001. View at Google Scholar
  23. S. Gates, P. Brocklehurst, and L. J. Davis, “Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period,” Cochrane Database of Systematic Reviews, no. 2, p. CD001689, 2002. View at Google Scholar · View at Scopus
  24. P. Brocklehurst, “Future research needs for venous thrombo-embolic disease in obstetrics and gynaecology,” Bailliere's Clinical Obstetrics and Gynaecology, vol. 11, no. 3, pp. 601–610, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. Royal College of Obstetricians and Gynaecologists, Thromboprophylaxis during Pregnancy, Labour and after Vaginal Delivery, Green-top Guideline Number 37, RCOG Press, London, UK, 2004.
  26. P. Brill-Edwards, J. S. Ginsberg, M. Gent et al., “Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this pregnancy study group,” The New England Journal of Medicine, vol. 343, pp. 1439–1444, 2000. View at Google Scholar
  27. J. A. Heit, C. E. Kobbervig, A. H. James, T. M. Petterson, K. R. Bailey, and L. J. Melton, “Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study,” Annals of Internal Medicine, vol. 143, no. 10, pp. 697–706, 2005. View at Google Scholar
  28. I. Pabinger, H. Grafenhofer, A. Kaider et al., “Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis,” Journal of Thrombosis and Haemostasis, vol. 3, no. 5, pp. 949–954, 2005. View at Publisher · View at Google Scholar · View at PubMed